SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016722
Filing Date
2022-04-29
Accepted
2022-04-29 06:06:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20003245x2_defa14a.htm DEFA14A 10453
2 ny20003245x2_nc01.jpg GRAPHIC 758319
3 ny20003245x2_nc02.jpg GRAPHIC 530890
  Complete submission text file 0001140361-22-016722.txt   1787358
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39303 | Film No.: 22869843
SIC: 2834 Pharmaceutical Preparations